RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 161 filers reported holding RELAY THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.30 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,184,540 | +308.4% | 140,849 | +509.9% | 0.15% | +272.5% |
| Q2 2023 | $290,036 | -7.0% | 23,092 | +65.5% | 0.04% | -14.9% |
| Q3 2022 | $312,000 | -83.5% | 13,953 | -87.7% | 0.05% | -71.9% |
| Q2 2022 | $1,895,000 | +34.0% | 113,151 | +139.6% | 0.17% | +36.9% |
| Q1 2022 | $1,414,000 | -34.3% | 47,234 | -32.6% | 0.12% | -25.6% |
| Q4 2021 | $2,153,000 | -22.1% | 70,100 | -20.0% | 0.16% | -17.6% |
| Q3 2021 | $2,764,000 | – | 87,652 | – | 0.20% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |